ARTICLE | Top Story
Symlin panel set for July
May 14, 2001 7:00 AM UTC
The FDA's Endocrinologic and Metabolic Drugs Advisory Committee will review on July 26 Amylin's NDA for Symlin pramlintide, a human amylin analog, as an adjunctive treatment for Type I or insulin-usin...